MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
39.09
+0.27
+0.70%
Opening 12:24 02/08 EST
OPEN
38.96
PREV CLOSE
38.82
HIGH
39.09
LOW
38.82
VOLUME
148.39K
TURNOVER
5.78M
52 WEEK HIGH
53.86
52 WEEK LOW
37.31
MARKET CAP
200.27B
P/E (TTM)
2.353
1D
5D
1M
3M
1Y
5Y
Bayer gains as former Roche pharma head becomes CEO
Seeking Alpha · 44m ago
TG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapy
Seeking Alpha · 1d ago
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
Benzinga · 1d ago
Roche's less frequently dosed crovalimab matches Soliris, meets phase 3 trial goals in rare blood disorder
Seeking Alpha · 1d ago
Poseida Therapeutics: New Allogeneic Therapies, Leveraging Non-Viral Engineering
Seeking Alpha · 1d ago
Outlook draws bullish views at Cantor on potential FDA nod for lead asset
Seeking Alpha · 1d ago
Biogen: What To Do Ahead Of Q4 2022 Financial Report
Seeking Alpha · 2d ago
Week In Review: Structure Stages $161 Million U.S. IPO For AI/Structure-Based Drug Development
Seeking Alpha · 2d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers kinds of Roche Holding AG (ADR) stock information, including OTCQX:RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.